Streetbeat News

Analyst Ratings

COP

Jefferies analyst Lloyd Byrne maintains a Buy rating on ConocoPhillips (NYSE:COP) but lowers the price target from $143 to $141.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:33 pm

PXD

Jefferies analyst Lloyd Byrne maintains a 'Hold' rating on Pioneer Natural Resources (NYSE:PXD) and raises the price target from $245 to $265.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:32 pm

EOG

Jefferies analyst Lloyd Byrne maintains a Buy rating on EOG Resources (NYSE:EOG) and raises the price target from $141 to $147.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:31 pm

CNQ

Jefferies analyst Lloyd Byrne has maintained a 'Hold' rating on Canadian Natural Res (NYSE:CNQ) and raised the price target from C$84 to C$94.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:24 pm

AMGN

CVS

PFE

The most accurate Wall Street analysts recommend holding three high-yielding healthcare stocks: Pfizer Inc. (PFE), Amgen Inc. (AMGN), and CVS Health Corporation (CVS). These companies have dividend yields of 4.50%, 3.32%, and 3.59% respectively. Recent news includes FDA approval of Pfizer's Abrysvo vaccine, Amgen's strong Q2 earnings and raised FY23 outlook, and CVS Health's better-than-expected Q2 financial results.

Portfolio Pulse from Lisa Levin

August 28, 2023 | 12:21 pm

APA

Jefferies analyst Lloyd Byrne maintains a 'Hold' rating on APA (NASDAQ:APA) and raises the price target from $39 to $43.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:14 pm

BIVI

BioVie Inc. (NASDAQ:BIVI) presented new preclinical and Phase 2a study data for its drug NE3107 at the 2023 International Congress of Parkinson's Disease and Movement Disorders. The data supports the potential of NE3107 as a co-administration with carbidopa/levodopa and as a first-line therapy in Parkinson's Disease. The company also announced that it is looking forward to the topline data readout from its Phase 3 Alzheimer's trial later this fall.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:09 pm

ICCM

IceCure Medical Ltd. (NASDAQ:ICCM) has appointed Shad Good as Vice President of Sales for North America. Good will be responsible for building a sales infrastructure in anticipation of a broader commercialization of the company's ProSense System in the U.S. and Canada. The company is awaiting the FDA's response to its regulatory filing for early-stage low risk breast cancer in patients who are at high risk for surgery.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:06 pm

WK

Over the past 3 months, 4 analysts have given Workiva (NYSE:WK) stock 2 bullish and 2 somewhat bullish ratings. The average price target is $123.5, implying an upside from the current price of $100.06. The average price target has increased by 14.35% over the past month.

Portfolio Pulse from Benzinga Insights

August 28, 2023 | 12:01 pm

EGHT

Analysts have provided ratings for 8x8 (NASDAQ:EGHT) in the last quarter, with 5 bullish and 2 indifferent ratings. The company has an average 12-month price target of $5.11, a decrease of 18.24% from the previous average price target of $6.25.

Portfolio Pulse from Benzinga Insights

August 28, 2023 | 12:01 pm